Regulatory & Legal

As private equity giant EIG sells its entire stake, Diversified Energy counters by repurchasing nearly half the shares in a bold vote of confidence.

With billions in government and private backing, USA Rare Earth hires legal, policy, and finance heavyweights to challenge China's grip on critical minerals.

A Texas hospital settled with an employee denied a religious exemption for a flu shot, highlighting a growing legal war over individual rights and public health.

The parent of Meineke and Maaco admits to 'material errors' in its financials, triggering a massive stock sell-off and a wave of investor lawsuits.

Neros Technologies delivers early on a key U.S. Army drone program and launches its next-gen, field-reconfigurable FPV system for modern warfighters.

An attorney's feature for International Women's Day sheds light on her dual role as counselor and the broader, changing landscape for women in the legal field.

Emalex Biosciences offers its investigational drug ecopipam to Tourette syndrome patients out of options, signaling a potential shift in treatment.

A Frisco mom's lawsuit claims surveillance video shows caregivers abusing her toddler, while management allegedly hid the evidence and ignored state warnings.

As party insiders meet, one GOP candidate is looking past the convention hall to a new force in New Mexico politics: the state's rising tide of independent voters.

A decorated 42-year Army veteran joins M1 Support Services to spearhead a radical, tech-driven transformation of how the Army trains helicopter pilots.

A North Carolina startup claims a massive efficiency leap in Direct Air Capture, putting the sub-$100/ton 'holy grail' of carbon removal within reach.

A startup using trained dogs and AI to sniff out cancer from breath samples was just named a "Fierce 15" company. Can this technology change screening?

With 8x sales growth and 90% prediction accuracy, AI pioneer QuantHealth is proving that simulating clinical trials can slash pharma's $50B failure rate.

The firm is integrating MSCI's advanced analytics platform, signaling a major shift towards hyper-personalized, data-driven advice for its clients.

Barfresh secures major financing to own its factory, aiming for massive growth. But as it navigates a complex deal, will the financial gamble pay off?

A novel stent designed specifically for the brain's veins shows immediate success in its first human tests, offering new hope for a debilitating condition.

A landmark European approval for Elfabrio allows stable Fabry disease patients to switch to monthly infusions, promising greater freedom and lower healthcare strain.

After a dramatic 2025 pivot from citrus, Alico's CEO is meeting investors to sell a new vision for its vast Florida land holdings and future growth.

As electroCore preps its 2025 financial report, all eyes are on its product growth, the new Quell device, and its path to profitability in the booming bioelectronic market.

With a new chairman at the helm, NATSO's 2026 board is set to navigate the complex challenges of EV charging, new regulations, and evolving customer demands.